Wall Street analysts expect Cavium Inc (NASDAQ:CAVM) to post $0.81 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Cavium’s earnings, with the highest EPS estimate coming in at $0.81 and the lowest estimate coming in at $0.79. Cavium reported earnings of $0.56 per share during the same quarter last year, which would suggest a positive year over year growth rate of 44.6%. The business is scheduled to issue its next earnings results on Wednesday, February 7th.

On average, analysts expect that Cavium will report full year earnings of $2.82 per share for the current financial year, with EPS estimates ranging from $2.79 to $2.82. For the next financial year, analysts forecast that the firm will report earnings of $3.57 per share, with EPS estimates ranging from $3.40 to $3.67. Zacks’ earnings per share calculations are an average based on a survey of sell-side analysts that follow Cavium.

Cavium (NASDAQ:CAVM) last announced its quarterly earnings data on Wednesday, November 1st. The semiconductor provider reported $0.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.74 by $0.02. The company had revenue of $251.99 million for the quarter, compared to analysts’ expectations of $250.16 million. Cavium had a negative net margin of 19.94% and a positive return on equity of 11.16%. Cavium’s revenue was up 49.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.43 EPS.

Several equities analysts have issued reports on the stock. Jefferies Group cut shares of Cavium from a “buy” rating to a “hold” rating in a research note on Tuesday, November 21st. Canaccord Genuity boosted their price objective on shares of Cavium from $66.00 to $67.00 and gave the company a “hold” rating in a research note on Thursday, November 2nd. Loop Capital cut shares of Cavium from a “buy” rating to a “hold” rating and set a $84.00 price objective on the stock. in a research note on Tuesday, November 21st. BidaskClub cut shares of Cavium from a “buy” rating to a “hold” rating in a research note on Thursday, December 7th. Finally, Morgan Stanley dropped their price objective on shares of Cavium from $78.00 to $77.00 and set an “overweight” rating on the stock in a research note on Thursday, November 2nd. One analyst has rated the stock with a sell rating, ten have issued a hold rating and nine have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $78.41.

In related news, VP Anil Kumar Jain sold 8,500 shares of the business’s stock in a transaction dated Tuesday, November 21st. The shares were sold at an average price of $85.90, for a total value of $730,150.00. Following the sale, the vice president now directly owns 91,616 shares in the company, valued at approximately $7,869,814.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Vincent P. Pangrazio sold 15,000 shares of the business’s stock in a transaction dated Friday, November 10th. The stock was sold at an average price of $77.22, for a total transaction of $1,158,300.00. Following the completion of the sale, the senior vice president now owns 60,039 shares in the company, valued at $4,636,211.58. The disclosure for this sale can be found here. 4.65% of the stock is owned by insiders.

Institutional investors have recently added to or reduced their stakes in the stock. Havens Advisors LLC acquired a new position in Cavium in the 4th quarter valued at about $3,437,000. Schwab Charles Investment Management Inc. raised its stake in Cavium by 7.1% in the 4th quarter. Schwab Charles Investment Management Inc. now owns 320,161 shares of the semiconductor provider’s stock valued at $26,840,000 after purchasing an additional 21,255 shares during the last quarter. Bank of Montreal Can raised its stake in Cavium by 605.4% in the 4th quarter. Bank of Montreal Can now owns 6,186 shares of the semiconductor provider’s stock valued at $519,000 after purchasing an additional 5,309 shares during the last quarter. Sheets Smith Wealth Management acquired a new position in Cavium in the 4th quarter valued at about $386,000. Finally, Public Employees Retirement System of Ohio raised its stake in Cavium by 18.6% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 214,208 shares of the semiconductor provider’s stock valued at $14,125,000 after purchasing an additional 33,539 shares during the last quarter.

Shares of Cavium (CAVM) traded up $0.11 on Wednesday, reaching $89.62. 573,461 shares of the company’s stock traded hands, compared to its average volume of 1,016,718. The company has a quick ratio of 2.27, a current ratio of 2.87 and a debt-to-equity ratio of 0.81. The firm has a market cap of $6,200.00, a PE ratio of -31.89, a P/E/G ratio of 2.20 and a beta of 1.35. Cavium has a 12 month low of $56.96 and a 12 month high of $90.83.

ILLEGAL ACTIVITY NOTICE: This report was first posted by American Banking News and is the property of of American Banking News. If you are accessing this report on another publication, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this report can be read at https://www.americanbankingnews.com/2018/01/17/zacks-brokerages-anticipate-cavium-inc-cavm-will-announce-earnings-of-0-81-per-share.html.

About Cavium

Cavium, Inc is a provider of integrated semiconductor processors that enable intelligent processing for wired and wireless infrastructure and cloud for networking, communications, storage and security applications. The Company’s products consist of multi-core processors for embedded and data center applications, network connectivity for server and switches, storage connectivity, and security processors for offload and appliance.

Get a free copy of the Zacks research report on Cavium (CAVM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cavium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavium and related companies with MarketBeat.com's FREE daily email newsletter.